Bioengineering & Translational Medicine

Bioengineering & Translational Medicine is an official quarterly, peer-reviewed, online, open access journal of the American Institute of Chemical Engineers (AIChE) and its technological community, the Society for Biological Engineering (SBE), published on our behalf by John Wiley & Sons. The inaugural issue debuted in 2016. The journal web page on the Wiley Online Library is online at http://bioengtransmed.com.

Bioengineering & Translational Medicine is focused on the fundamental ways chemical and biological engineering approaches drive and provide innovative technologies and solutions that impact clinical practice and/or commercial healthcare products. The journal includes research reports, reviews, and rapid communications with a focus on biomolecular engineering advances.

Topics covered in Bioengineering & Translational Medicine include:

• Drug delivery
• Drug discovery and development
• Tissue engineering
• Chemical engineering-based bioprocessing
• Synthetic biology
• Biosensors
• Organoids and organ-mimetic systems
• Stem cell therapies
• Gene therapies
• Immunotherapies
• Patient-targeted therapies
• Medical devices
• Regenerative medicine
• Implant/patient interface
• Compounds/materials
• Nanobiology
• Computational modeling
• Bioinformatics

Readership

Chemical engineers; biological engineers, biomolecular engineers, biomedical engineers, and other engineers and professionals with specific interests in translational medicine, biotechnology, and biochemical and biomolecular engineering; physicians and other healthcare researchers and professionals

Editor-in-Chief

Samir Mitragotri, Hiller Professor of Bioengineering at the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS); Wyss Professor of Biologically Inspired Engineering at Harvard’s Wyss Institute. See bio

Information for Authors

Editorial Advisory Board

• Maria Jose Alonso, University of Santiago de Compostela, Spain
• Kristi Anseth, University of Colorado Boulder
• Xiaoyan Chen, National Institutes of Health
• Mark Davis, California Institute of Technology
• Michael Deem, Rice University
• Francis J. Doyle III, Harvard University
• George Georgiou, University of Texas, Austin
• Linda Griffith, Massachusetts Institute of Technology
• Paula Hammond, Massachusetts Institute of Technology
• Justin Hanes, Johns Hopkins University
• Ravi Kane, Georgia Institute of Technology
• Ali Khademhosseini, Harvard University
• Chaitan Khosla, Stanford University
• Richard Korsmeyer, Pfizer 
• Cato Laurencin, University of Connecticut
• Andreas Lendlein, Hemlholtz Institute of Biomaterial Science, Germany
• Raghunath A. Mashelkar, CSIR-National Chemical Laboratory, India
• Antonios Mikos, Rice University
• David Mooney, Harvard University
• Nicholas Peppas, University of Texas, Austin
• Mark Prausnitz, Georgia Institute of Technology
• W. Mark Saltzman, Yale University
• David Schaffer, University of California, Berkeley
• Gregory Stephanopoulos, Massachusetts Institute of Technology
• Molly Stevens, Imperial College, London
• David Tirrell, California Institute of Technology
• Matthew Tirrell, University of Chicago
• Subbu Venkatraman, Nanyang Technological University, Singapore
• Jennifer West, Rice University
• Jackie Ying, A*-STAR, Institute of Bioengineering and Nanotechnology